News + Filings Holdings
|
|
Finepoint Capital LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
Travere Therapeutics, Inc.
| TVTX | Common | 761,721 | -113,500 | 11,700,035,000 | -7,983,685,000 | 4.05 | 1.18 |
Hist
| 06/30/2023 |
|
Relay Therapeutics, Inc.
| RLAY | Stock | 701,570 | -144,700 | 8,811,719,000 | -5,126,348,000 | 3.05 | 0.58 |
Hist
| 06/30/2023 |
|
Ascendis Pharma A/S
| ASND | SPONSORED ADR | 139,772 | -16,300 | 12,474,651,000 | -4,259,389,000 | 4.32 | |
Hist
| 06/30/2023 |
|
Arvinas, Inc.
| ARVN | Common | 411,500 | -80,800 | 10,213,430,000 | -3,236,206,000 | 3.53 | |
Hist
| 06/30/2023 |
|
CYTOKINETICS INC
| CYTK | COM NEW | 369,093 | -44,700 | 12,039,814,000 | -2,521,562,000 | 4.17 | 0.39 |
Hist
| 06/30/2023 |
|
GALAPAGOS NV
| GLPG | SPON ADR | 406,859 | -37,800 | 16,542,887,000 | -638,737,000 | 5.72 | |
Hist
| 06/30/2023 |
|
SpringWorks Therapeutics, Inc.
| SWTX | Common | 608,628 | -5,603 | 15,958,226,000 | 147,920,000 | 5.52 | 0.97 |
Hist
| 06/30/2023 |
|
Crinetics Pharmaceuticals, Inc.
| CRNX | Common | 797,527 | -70,900 | 14,371,437,000 | 424,499,000 | 4.97 | 1.48 |
Hist
| 06/30/2023 |
|
AMICUS THERAPEUTICS, INC.
| FOLD | COM | 1,325,775 | -134,400 | 16,651,734,000 | 458,393,000 | 5.76 | 0.47 |
Hist
| 06/30/2023 |
|
Sage Therapeutics, Inc.
| SAGE | COM | 357,765 | -31,100 | 16,822,110,000 | 505,335,000 | 5.82 | |
Hist
| 06/30/2023 |
|
Cerevel Therapeutics Holdings, Inc.
| CERE | Common | 492,545 | -46,900 | 15,658,006,000 | 2,500,942,000 | 5.42 | 0.31 |
Hist
| 06/30/2023 |
|
ACADIA PHARMACEUTICALS INC
| ACAD | Common | 846,953 | -69,400 | 20,284,524,000 | 3,038,761,000 | 7.02 | 0.52 |
Hist
| 06/30/2023 |
|
Paragon Airheater Technologies, Inc.
| APLS | COM | 241,690 | -42,000 | 22,017,959,000 | 3,305,767,000 | 7.62 | |
Hist
| 06/30/2023 |
|
PROTHENA CORP PUBLIC LTD CO
| PRTA | Common | 317,300 | -14,300 | 21,665,244,000 | 5,592,592,000 | 7.50 | 0.60 |
Hist
| 06/30/2023 |
|
|
|
|